Correlation Engine 2.0
Clear Search sequence regions


  • case report (1)
  • edema (7)
  • herbal (1)
  • humans (1)
  • leg edema (4)
  • levofloxacin (11)
  • medicines (1)
  • patient (4)
  • pneumonia (1)
  • Sizes of these terms reflect their relevance to your search.

    A number of medicines are associated with edema. However, only 2 cases of edema of both lower legs, associated with levofloxacin, have been reported. We report the case of levofloxacin-associated bilateral leg edema in an 81-year-old male. The patient was referred to the Division of Nephrology due to edema limited to both lower legs, which had developed 1 day before. He had undergone supraglottic laryngectomy due to supraglottic cancer in our institution 6 months ago. He had been admitted to the Department of Otolaryngology due to persistent aspiration and general weakness 5 days ago. The patient had no underlying diseases that could result in edema. No abnormalities were detected in several diagnostic tests. He strongly denied using other medications including herbal or traditional remedies, recreational drugs, or drugs of abuse. The patient had been intravenously administered levofloxacin at 750 mg per day 5 days earlier; on this basis levofloxacin-induced edema was suspected. Levofloxacin was immediately withdrawn and conservative management (salt restriction and withdrawal of intravenous fluid) was initiated. His edema was completely restored within 3 weeks after withdrawal of levofloxacin. The patient stopped taking levofloxacin and he did not have any recurrent edema until his death due to uncontrolled pneumonia. Levofloxacin should be added to the list of drugs associated with the development of bilateral leg edema. This might obviate the need for time-consuming studies for diagnostic purposes and application of ineffective or harmful treatments.

    Citation

    Jeonggu Na, Tae Won Lee, Eunjin Bae, Eun Ju Lee, Ha Nee Jang, Hyun Seop Cho, Se-Ho Chang, Dong Jun Park. A case of bilateral leg edema associated with levofloxacin: A case report. Medicine. 2019 Jul;98(30):e16581

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 31348293

    View Full Text